Abstract
A patient received methazolamide (Neptazane) therapy [for glaucoma]. After initiation of the therapy (3 wk), a protracted jaundice with intrahepatic cholestasis developed, and 5 wk later a pure RBC [red blood cell] aplasia developed. There was total recovery from both conditions.

This publication has 2 references indexed in Scilit: